S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
S&P 500   3,310.11 (+1.19%)
DOW   26,659.11 (+0.52%)
QQQ   276.39 (+1.75%)
AAPL   115.32 (+3.71%)
MSFT   204.72 (+1.01%)
FB   280.83 (+4.92%)
GOOGL   1,556.88 (+3.05%)
AMZN   3,211.01 (+1.52%)
TSLA   410.83 (+1.18%)
NVDA   520.96 (+3.14%)
BABA   312.56 (+1.50%)
CGC   18.78 (+2.40%)
GE   7.37 (-0.67%)
MU   50.48 (+0.96%)
AMD   78.02 (+2.12%)
T   26.76 (+0.98%)
F   7.90 (+2.60%)
ACB   4.09 (+6.79%)
GILD   58.53 (-0.32%)
NFLX   504.21 (+3.70%)
NIO   31.99 (+16.28%)
BA   148.29 (+0.10%)
DIS   121.54 (+2.59%)
Log in
OTCMKTS:CBNT

C-Bond Systems Stock Forecast, Price & News

$0.01
+0.00 (+8.33 %)
(As of 10/29/2020 03:58 PM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01▼
$0.02
50-Day Range
$0.01
MA: $0.01▼
$0.03
52-Week Range
$0.01
Now: $0.01▼
$0.18
Volume398,609 shs
Average Volume1.07 million shs
Market Capitalization$3.08 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
C-Bond Systems, Inc. owns, develops, manufactures, and sells patented C-Bond technology in the United Sates. Its products include C-Bond NanoShield, a patented nanotechnology windshield glass strengthening and hydrophobic all-in-one performance system to enhance windshield safety and performance; C-Bond I, a patented non-toxic water-based nanotechnology solution to enhance glasses and properties of window film-to-glass products; and C-Bond BRS, a patented nanotechnology ballistic resistant film system that enhances the structural integrity of glass. The company serves primarily to glass industry. C-Bond Systems, Inc. was founded in 2013 and is headquartered in Houston, Texas.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.67 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Investors, not elsewhere classified
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolOTCMKTS:CBNT
Previous Symbol
CUSIPN/A
CIK1610462
Webwww.cbondsystems.com
Phone832-649-5658
Employees8

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$600,000.00
Price / Sales5.13
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares215,147,000
Market Cap$3.08 million
Next Earnings Date11/16/2020 (Estimated)
OptionableNot Optionable
$0.01
+0.00 (+8.33 %)
(As of 10/29/2020 03:58 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CBNT News and Ratings via Email

Sign-up to receive the latest news and ratings for CBNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











C-Bond Systems (OTCMKTS:CBNT) Frequently Asked Questions

How has C-Bond Systems' stock price been impacted by COVID-19 (Coronavirus)?

C-Bond Systems' stock was trading at $0.0550 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CBNT shares have decreased by 74.0% and is now trading at $0.0143.
View which stocks have been most impacted by COVID-19.

When is C-Bond Systems' next earnings date?

C-Bond Systems is scheduled to release its next quarterly earnings announcement on Monday, November 16th 2020.
View our earnings forecast for C-Bond Systems.

How were C-Bond Systems' earnings last quarter?

C-Bond Systems, Inc. (OTCMKTS:CBNT) issued its earnings results on Monday, August, 17th. The company reported ($0.01) EPS for the quarter, beating the Zacks' consensus estimate of ($0.02) by $0.01. The firm had revenue of $0.04 million for the quarter.
View C-Bond Systems' earnings history.

Are investors shorting C-Bond Systems?

C-Bond Systems saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 23,200 shares, an increase of 157.8% from the September 30th total of 9,000 shares. Based on an average daily volume of 1,991,400 shares, the days-to-cover ratio is presently 0.0 days.
View C-Bond Systems' Short Interest.

Who are some of C-Bond Systems' key competitors?

Some companies that are related to C-Bond Systems include BILOXI MARSH LA/SH (BLMC), TAAT Lifestyle & Wellness (MOLOF), Mentor Capital (MNTR), CVF Technologies (CNVT), Ampal American Israel (AMPLQ) and Andover Mining (AOVTF).
View all competitors.

What other stocks do shareholders of C-Bond Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other C-Bond Systems investors own include Allena Pharmaceuticals (ALNA), Arbutus Biopharma (ABUS), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS), Ardelyx (ARDX), ArQule (ARQL) and Athersys (ATHX).

Who are C-Bond Systems' key executives?

C-Bond Systems' management team includes the following people:
  • Mr. Scott R. Silverman, Chairman & CEO (Age 56, Pay $561.37k)
  • Mr. Vincent Joseph Alfred Pugliese, Pres, COO, Interim CFO, Treasurer & Director (Age 57, Pay $358.39k)
  • Dr. Andrew R. Barron, Chief Technology Officer
  • Dr. Enrique Barrera, Chief Science Advisor
  • Mr. Brian P. Fenske, Legal Counsel & Member of Advisory Board
  • Ms. Allison F. Tomek, VP of Corp. Communications & Sec.
  • Mr. Craig Steinroeder, VP of Sales & Bus. Devel.

What is C-Bond Systems' stock symbol?

C-Bond Systems trades on the OTCMKTS under the ticker symbol "CBNT."

How do I buy shares of C-Bond Systems?

Shares of CBNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is C-Bond Systems' stock price today?

One share of CBNT stock can currently be purchased for approximately $0.01.

How big of a company is C-Bond Systems?

C-Bond Systems has a market capitalization of $3.08 million and generates $600,000.00 in revenue each year. C-Bond Systems employs 8 workers across the globe.

What is C-Bond Systems' official website?

The official website for C-Bond Systems is www.cbondsystems.com.

How can I contact C-Bond Systems?

C-Bond Systems' mailing address is 6035 SOUTH LOOP EAST, HOUSTON TX, 77033. The company can be reached via phone at 832-649-5658 or via email at [email protected]

This page was last updated on 10/29/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.